Agios Pharmaceuticals
AGIO
£28.25
Share price
1.42%
Change (1 day)
-23.53%
Change (1 year)
Categories
Earnings for Agios Pharmaceuticals (AGIO)
Earnings in 2025 (TTM): -£0.35 Billion
According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are £37.03 Million. In 2024 the company made an earning of -£0.32 Billion a decrease over its 2023 earnings that were of -£0.3 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Agios Pharmaceuticals from 2012 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -£0.35 Billion | 7.49% |
| 2024 | -£0.32 Billion | 8.75% |
| 2023 | -£0.3 Billion | 0.63% |
| 2022 | -£0.3 Billion | 2.81% |
| 2021 | -£0.29 Billion | 10.58% |
| 2020 | -£0.26 Billion | -18.41% |
| 2019 | -£0.32 Billion | 15.72% |
| 2018 | -£0.28 Billion | 12.99% |
| 2017 | -£0.25 Billion | 59.61% |
| 2016 | -£0.16 Billion | 69.32% |
| 2015 | -£88.89 Million | 119.28% |
| 2014 | -£40.54 Million | 39.22% |
| 2013 | -£29.12 Million | 69.1% |
| 2012 | -£17.22 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | -£0.17 Billion | -50.69% | 🇺🇸 USA |
 Exelixis EXEL | £0.62 B | -290.34% | 🇺🇸 USA |
 Pfizer PFE | £7.74 B | -2,448.66% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | £0.50 B | -253.15% | 🇺🇸 USA |
 GlaxoSmithKline GSK | £4.04 B | -1,328.00% | 🇬🇧 UK |
 Eli Lilly LLY | £10.18 B | -3,188.94% | 🇺🇸 USA |